Variant report
Variant | nsv518149 |
---|---|
Chromosome Location | chr7:14113503-14118349 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr7:14113767-14113895 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr7:14117611-14117889 | A549 | lung: | n/a | chr7:14117713-14117726 chr7:14117713-14117724 chr7:14117714-14117725 |
3 | CEBPB | chr7:14117589-14117774 | HepG2 | liver: | n/a | chr7:14117713-14117726 chr7:14117713-14117724 chr7:14117714-14117725 |
4 | GATA3 | chr7:14113424-14113922 | SK-N-SH | brain: | n/a | n/a |
5 | GATA3 | chr7:14113611-14113621 | SH-SY5Y | brain: | n/a | n/a |
6 | GATA3 | chr7:14114137-14114143 | SH-SY5Y | brain: | n/a | n/a |
7 | MXI1 | chr7:14114241-14114322 | GM12878 | blood: | n/a | n/a |
8 | SPI1 | chr7:14113124-14113626 | HL-60 | blood: | n/a | chr7:14113391-14113400 chr7:14113389-14113402 chr7:14113390-14113403 |
9 | STAT3 | chr7:14118101-14118265 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | USF2 | chr7:14115360-14115376 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:14116104..14118348-chr7:14120734..14122252,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL6P21 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2884306 | chr7:14113503-14113504 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs531960167 | chr7:14113519-14113520 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs547256088 | chr7:14113539-14113540 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs116793592 | chr7:14113542-14113543 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs529358134 | chr7:14113565-14113566 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs528782665 | chr7:14113582-14113583 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs190140695 | chr7:14113586-14113587 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs10260700 | chr7:14113597-14113598 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs537145134 | chr7:14113599-14113600 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs377246433 | chr7:14113621-14113622 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs565120526 | chr7:14113622-14113623 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs567331766 | chr7:14113649-14113650 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs182377643 | chr7:14113712-14113713 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs552911345 | chr7:14113713-14113714 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs187671473 | chr7:14113773-14113774 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs141387231 | chr7:14113897-14113898 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs150388154 | chr7:14113900-14113901 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs546619634 | chr7:14113910-14113911 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs575359441 | chr7:14113924-14113925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543965908 | chr7:14113968-14113969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566420298 | chr7:14113978-14113979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554685231 | chr7:14114004-14114005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538570899 | chr7:14114030-14114031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192593688 | chr7:14114086-14114087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559713549 | chr7:14114108-14114109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6975368 | chr7:14114136-14114137 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs545341123 | chr7:14114172-14114173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376107489 | chr7:14114173-14114174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569041289 | chr7:14114271-14114272 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs184043650 | chr7:14114305-14114306 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs56867158 | chr7:14114316-14114317 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs60121356 | chr7:14114331-14114332 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs538079620 | chr7:14114358-14114359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372430280 | chr7:14114395-14114396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375548556 | chr7:14114418-14114419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138142654 | chr7:14114430-14114431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554337205 | chr7:14114437-14114438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530149996 | chr7:14114466-14114467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574641876 | chr7:14114486-14114487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371205538 | chr7:14114489-14114490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188974231 | chr7:14114503-14114504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566678568 | chr7:14114504-14114505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538935121 | chr7:14114531-14114532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558936137 | chr7:14114533-14114534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568857703 | chr7:14114534-14114535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192344394 | chr7:14114555-14114556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537165231 | chr7:14114564-14114565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184508075 | chr7:14114566-14114567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574440042 | chr7:14114581-14114582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539961855 | chr7:14114592-14114593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:14112400-14114000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr7:14113000-14114200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr7:14113000-14115000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr7:14113000-14115400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |